Strategies for the Management of Suspected Heparin-Induced Thrombocytopenia: A Cost-Effectiveness Analysis

Author： Patrick Amanda R.   Winkelmayer Wolfgang C.   Avorn Jerry   Fischer Michael A.  

Publisher： Adis International

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.25, Iss.11, 2007-01, pp. : 949-961

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Management of heparin-induced thrombocytopenia

By Jaax Miriam E.   Greinacher Andreas  

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 7, 2012-05 ,pp. : 987-1006

Informa Healthcare

Access to resources Recommend Favorite

Lepirudin in the management of heparin-induced thrombocytopenia

By Gajra Ajeet   Husain Juhi   Smith Adrienne  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 4, Iss. 8, 2008-08 ,pp. : 1131-1141

Informa Healthcare

Access to resources Recommend Favorite

The Direct Medical Costs Associated with Suspected Heparin-Induced Thrombocytopenia

By Nanwa Natasha  

PharmacoEconomics, Vol. 29, Iss. 6, 2011-06 ,pp. : 511-520

Adis International

Access to resources Recommend Favorite

Pharmacotherapy of heparin-induced thrombocytopenia

By Dager William E   White Richard H  

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 6, 2003-06 ,pp. : 919-940

Informa Healthcare

Access to resources Recommend Favorite

Argatroban: A Review of its Use in the Management of Heparin-Induced Thrombocytopenia

By Dhillon Sohita  

American Journal of Cardiovascular Drugs, Vol. 9, Iss. 4, 2009-08 ,pp. : 261-282

Adis International

Access to resources Recommend Favorite